Entrada Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
MPM BioVentures entities and associated individuals have amended their Schedule 13D filing to report open market sales of Entrada Therapeutics common stock.
NASDAQ
5AM Ventures and affiliates disclosed selling 200,000 Entrada shares and updated beneficial ownership stakes ranging from 2.9% to 10.8%.